Title: Vaccines Market to grow at 9% CAGR from 2017 to 2024
1Global Vaccines Market to hit 65 Bn by 2024
Global Market Insights Inc.
2Key Insights from Vaccines Market
- The global vaccines market has recently witnessed
one of its key participants, Novartis NVS
announcing its decision to acquire the France
based radiopharmaceutical company, Advanced
Accelerator Applications (AAAP). - Global Market Insights, Inc. says, in 2016,
vaccines market size stood at a revenue of USD 32
billion. - This purchase apparently, is expected to
strengthen Novartis product portfolio in the
cancer vertical, by adding AAAPs RadioLigand
Therapy. - Currently, it has been observed most of the
pharmaceutical giants have been striving to come
up with innovative vaccination products for
influenza, which seems to be raging across the
globe in seasonal intervals. - The company also plans to recruit more workforce
to increase the production rate, so that the
vaccines can be shipped in readiness in case of a
pandemic. - Seqiruss investment is likely to encourage
regional vaccines industry players to follow
suit, which would subsequently help stimulate UK
vaccines market trends over the coming years.
3Continued...
- Regulatory organizations have been making
continuous efforts to generate awareness among
the global populace regarding the advantages of
vaccination. - For instance, the U.S. Centers for Disease
Control and Prevention (CDC) has inked guidelines
to encourage people to take seasonal influenza
vaccines for controlling and preventing the virus
from spreading, especially in young children, the
elderly, and pregnant women. - As per estimates, U.S. covered a major share of
the regional vaccines market revenue in 2016,
pertaining to the numerous efforts undertaken by
regulatory bodies. - Considering the myriad advantages that vaccines
provide to improve an individuals immunity
system, researchers have been striving to conduct
eminent study programs involving the methodology
of combining vaccines with other cancer treatment
methods such as radiations, chemotherapy, and
Herceptin to enhance patient survival rate. - Notable behemoths across the vaccines market,
namely, Merck Co., AstraZeneca, Pfizer,
Novartis, Bristol-Myers Squibb, CSL, Johnson
Johnson, Abbott, GlaxoSmithKline, Astellas
Pharma, Sanofi Pasteur, Novavax, and Emergent
BioSolutions
4U.S. Vaccines Market, By Age Group, 2013 - 2024
(USD Billion)
5Table of Content
Chapter 1. Methodology 1.1. Methodology
1.1.1. Initial data
exploration 1.1.2. Statistical modeling and
forecast 1.1.3. Industry insights and
validation 1.1.4. Market definition and
forecast assumptions 1.2. Data
sources 1.2.1. Primary 1.2.2.
Secondary Chapter 2. Executive Summary 2.1.
Global Vaccines industry 3600 synopsis, 2013 -
2024 2.1.1. Business trends 2.1.2. Age group
trends 2.1.3. Disease trends 2.1.4.
Technology trends 2.1.5. Regional trends
6Table of Content
Chapter 3. Vaccines Industry Insights 3.1.
Industry segmentation 3.2. Industry landscape,
2013 2024 3.3. Industry impact forces 3.3.1.
Growth drivers 3.3.1.1.Increasing government
funding for vaccine development 3.3.1.2.
Increasing vaccines RD in developed
nations 3.3.1.3. Increasing disease prevalence
in underdeveloped countries 3.3.1.4. Growing
incidences of cancer HIV in Asia
Pacific 3.3.2. Industry pitfalls
challenges 3.3.2.1. High cost of vaccine
storage and transportation 3.3.2.2. Stringent
regulations for the approval of vaccines in
developed nations 3.4. Growth potential
analysis 3.4.1. By age group 3.4.2. By
technology 3.4.3. By disease
7Table of Content
3.5. Regulatory landscape 3.5.1. U.S 3.5.2.
Europe 3.5.3. Asia Pacific 3.6. Reimbursement
scenario 3.6.1. U.S 3.6.2. Europe 3.7.
Technology landscape 3.8. Pricing analysis 3.9.
Pipeline product analysis 3.9.1.
Malaria 3.9.2. HIV 3.9.3. Zika 3.9.4.
Ebola 3.10. Porters analysis 3.11. Company
market share analysis, 2016 3.11.1. Strategy
dashboard 3.12. PESTEL analysis
8 Browse Full Market Research Report On Vaccines
Market _at_ http//bit.ly/2A49oxa Request for a
Sample of this Research Report _at_ https//www.gmins
ights.com/request-sample/detail/2186
https//www.gminsights.com/request-sample/detail/4
9
9 Stay In Touch Website www.gminsights.com Soci
al Media